Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis

BACKGROUND: First-line treatments for nonsmall cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations have been evaluated in various clinical trials. However, it remains unclear which is the optimal treatment. METHODS: A Bayesian network meta-analysis was used to assess...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Adv Med Oncol
Egile Nagusiak: Zhang, Zhonghan, Zeng, Kangmei, Zhao, Shen, Zhao, Yuanyuan, Hou, Xue, Luo, Fan, Lu, Feiteng, Zhang, Yaxiong, Zhou, Ting, Ma, Yuxiang, Yang, Yunpeng, Fang, Wenfeng, Huang, Yan, Zhang, Li, Zhao, Hongyun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2019
Gaiak:
Meta-Analysis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6937538/
https://ncbi.nlm.nih.gov/pubmed/31908655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919891652
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak